---
title: 'The Niche Episode 012 – Probiotics, Lipid Nanoparticles, Transparency, and Immuno-therapy'
type: 'episode'
url: 'https://doc.social/episodes/the-niche-episode-012-probiotics-lipid-nanoparticles-transparency-and-immuno-therapy'
show: 'Life Science Today'
show_url: 'https://doc.social/podcasts/life-science-today'
published: '2020-09-21'
audio: 'unavailable — the host retired the file'
---

# The Niche Episode 012 – Probiotics, Lipid Nanoparticles, Transparency, and Immuno-therapy

Finch does probiotics the expensive way, lipid nanoparticles, a followup on transparency, and LAVA gains immuno-therapy support.Sponsorshttps://www.thescopemethod.com Story Referenceshttps://www.businesswire.com/news/home/20200916005915/en/…

## Summary

Finch does probiotics the expensive way, lipid nanoparticles, a followup on transparency, and LAVA gains immuno-therapy support.

**Sponsors
**[https://www.thescopemethod.com](https://www.thescopemethod.com/)

**Story References
**[https://www.businesswire.com/news/home/20200916005915/en/Moderna-and-Vertex-Establish-New-Collaboration-to-Treat-Cystic-Fibrosis-Using-Gene-Editing](https://www.businesswire.com/news/home/20200916005915/en/Moderna-and-Vertex-Establish-New-Collaboration-to-Treat-Cystic-Fibrosis-Using-Gene-Editing)

[https://finchtherapeutics.com/blog/finch-therapeutics-announces-90-million-financing](https://finchtherapeutics.com/blog/finch-therapeutics-announces-90-million-financing)

[https://www.modernatx.com/sites/default/files/mRNA-1273-P301-Protocol.pdf](https://www.modernatx.com/sites/default/files/mRNA-1273-P301-Protocol.pdf)

[https://www.businesswire.com/news/home/20200916005913/en/LAVA-Therapeutics-Announces-83-million-Series-C-Financing-to-Advance-Novel-Immuno-Oncology-Programs](https://www.businesswire.com/news/home/20200916005913/en/LAVA-Therapeutics-Announces-83-million-Series-C-Financing-to-Advance-Novel-Immuno-Oncology-Programs)

**
**

**Music by Luke Goodson**

[https://www.soundcloud.com/lukegoodson](https://www.soundcloud.com/lukegoodson)